Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes

Background: Protocol biopsy in renal allograft helps to early detect subclinical rejection (SCR) in patients who have no abnormal clinical and laboratory findings. Still, there are rare reports about the techniques and outcomes of two-week protocol biopsy. The aim of this study was to assess two-wee...

Full description

Bibliographic Details
Main Authors: Manuel Lim, Byung Kwan Park, Kyo Won Lee, Jae Berm Park, Kyeong Deok Kim, Jaehun Yang, Jieun Kwon, Eun Sung Jeong, Seunghwan Lee
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/3/785
_version_ 1797486880346865664
author Manuel Lim
Byung Kwan Park
Kyo Won Lee
Jae Berm Park
Kyeong Deok Kim
Jaehun Yang
Jieun Kwon
Eun Sung Jeong
Seunghwan Lee
author_facet Manuel Lim
Byung Kwan Park
Kyo Won Lee
Jae Berm Park
Kyeong Deok Kim
Jaehun Yang
Jieun Kwon
Eun Sung Jeong
Seunghwan Lee
author_sort Manuel Lim
collection DOAJ
description Background: Protocol biopsy in renal allograft helps to early detect subclinical rejection (SCR) in patients who have no abnormal clinical and laboratory findings. Still, there are rare reports about the techniques and outcomes of two-week protocol biopsy. The aim of this study was to assess two-week protocol biopsy regarding the technical feasibility, procedure safety, and clinical outcomes. Methods: A total of 894 protocol biopsies were performed in adult recipients between 2012 and 2019. Two-week and one-year protocol biopsies were guided with ultrasound in 842 and 399 patients by one of four radiologists with wide range of biopsy experience, respectively. These protocol biopsies were compared in terms of feasibility and safety. Standard references were clinico-laboratory findings and biopsy examinations. Results: The median period of two-week and one-year protocol biopsies were 12 days (10–20 days) and 383 days (302–420 days), respectively. All protocol biopsies were technically successful and there was no difference between radiologists regarding technical success and complications (<i>p =</i> 0.453). Major complication (Clavien–Dindo grading II–IV) rates of two-week and one-year protocol biopsies were 0.3% (3/842) and 0.2% (1/399), respectively (<i>p =</i> 1.000). However, univariate analysis demonstrated that platelet count < 100 K/mL and blood urea nitrogen ≥ 40 mg/dL were associated with major complications in two-week protocol biopsy. The SCRs of these protocol biopsies were 15.4% (130/842) and 33.6% (134/399), respectively (<i>p <</i> 0.001). Conclusion: Two-week protocol biopsy is technically feasible and safe. It contributes to early detecting a substantial number of SCRs. Prior to the biopsy, platelet count and blood urea nitrogen should be carefully checked to predict major complications.
first_indexed 2024-03-09T23:39:39Z
format Article
id doaj.art-200e4fd76b71421b9e3cbb4c6039d6e4
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T23:39:39Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-200e4fd76b71421b9e3cbb4c6039d6e42023-11-23T16:53:57ZengMDPI AGJournal of Clinical Medicine2077-03832022-01-0111378510.3390/jcm11030785Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and OutcomesManuel Lim0Byung Kwan Park1Kyo Won Lee2Jae Berm Park3Kyeong Deok Kim4Jaehun Yang5Jieun Kwon6Eun Sung Jeong7Seunghwan Lee8Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Surgery, Kyung Hee University Hospital at Gangdong, Seoul 05278, KoreaBackground: Protocol biopsy in renal allograft helps to early detect subclinical rejection (SCR) in patients who have no abnormal clinical and laboratory findings. Still, there are rare reports about the techniques and outcomes of two-week protocol biopsy. The aim of this study was to assess two-week protocol biopsy regarding the technical feasibility, procedure safety, and clinical outcomes. Methods: A total of 894 protocol biopsies were performed in adult recipients between 2012 and 2019. Two-week and one-year protocol biopsies were guided with ultrasound in 842 and 399 patients by one of four radiologists with wide range of biopsy experience, respectively. These protocol biopsies were compared in terms of feasibility and safety. Standard references were clinico-laboratory findings and biopsy examinations. Results: The median period of two-week and one-year protocol biopsies were 12 days (10–20 days) and 383 days (302–420 days), respectively. All protocol biopsies were technically successful and there was no difference between radiologists regarding technical success and complications (<i>p =</i> 0.453). Major complication (Clavien–Dindo grading II–IV) rates of two-week and one-year protocol biopsies were 0.3% (3/842) and 0.2% (1/399), respectively (<i>p =</i> 1.000). However, univariate analysis demonstrated that platelet count < 100 K/mL and blood urea nitrogen ≥ 40 mg/dL were associated with major complications in two-week protocol biopsy. The SCRs of these protocol biopsies were 15.4% (130/842) and 33.6% (134/399), respectively (<i>p <</i> 0.001). Conclusion: Two-week protocol biopsy is technically feasible and safe. It contributes to early detecting a substantial number of SCRs. Prior to the biopsy, platelet count and blood urea nitrogen should be carefully checked to predict major complications.https://www.mdpi.com/2077-0383/11/3/785kidney transplantationprotocol biopsycomplication
spellingShingle Manuel Lim
Byung Kwan Park
Kyo Won Lee
Jae Berm Park
Kyeong Deok Kim
Jaehun Yang
Jieun Kwon
Eun Sung Jeong
Seunghwan Lee
Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes
Journal of Clinical Medicine
kidney transplantation
protocol biopsy
complication
title Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes
title_full Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes
title_fullStr Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes
title_full_unstemmed Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes
title_short Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes
title_sort two week protocol biopsy in renal allograft feasibility safety and outcomes
topic kidney transplantation
protocol biopsy
complication
url https://www.mdpi.com/2077-0383/11/3/785
work_keys_str_mv AT manuellim twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT byungkwanpark twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT kyowonlee twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT jaebermpark twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT kyeongdeokkim twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT jaehunyang twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT jieunkwon twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT eunsungjeong twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes
AT seunghwanlee twoweekprotocolbiopsyinrenalallograftfeasibilitysafetyandoutcomes